MPOX TRACKER

The Democratic Republic of Congo faces significant challenges in launching a mass mpox vaccination effort in its capital, Kinshasa, as cases rise sharply, especially among children. Despite a critical need for over 162,000 doses to vaccinate the city’s nearly 20 million residents, only 53,921 doses are available, primarily allocated to high-risk prison populations. The World Health Organization declared mpox a global health emergency in August due to a new strain spreading from Congo, but logistical and administrative delays have slowed vaccine arrivals from donors. Germany is expected to send 100,000 doses, though more support and efficient processing are urgently needed.

Meanwhile, the charity Save the Children highlights the growing risk to children in Congo, whose suspected mpox cases have surged by over 130% since August, reaching 25,600. Young children, with weaker immune systems and frequent close contact, are especially vulnerable. As Save the Children’s Katia Vieira de Moraes LaCasse noted, targeted vaccinations are critical to halt mpox’s spread among this group, who may struggle to adhere to health guidelines.

Global vaccine suppliers are ready to support, with Bavarian Nordic reporting that 265,000 Jynneos doses have already been delivered across Africa and an additional 1 million doses prepared for shipment. However, bureaucratic hurdles have delayed vaccine availability, requiring official requests, documentation, and import approvals. Africa CDC continues to call for timely vaccine distribution to address Congo’s urgent need.

As Congo contends with rising mpox infections, coordinated action among donors, health agencies, and African health authorities is essential. By expediting vaccine distribution, the international community can support Congo’s containment efforts, protecting vulnerable populations and preventing further spread.